Information Provided By:
Fly News Breaks for December 10, 2019
SNY, THOR
Dec 10, 2019 | 07:05 EDT
H.C. Wainwright analyst Debjit Chattopadhyay downgraded Synthorx (THOR) to Neutral from Buy with a price target of $68, up from $30. The analyst cites the takeover by Sanofi (SNY) for the downgrade.